Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: This study aims to evaluate the effectiveness and feasibility of the implementation of an Asthma Integrated Care Pathway (AICP) to improve care and reduce variability according to recommended clinical practice guidelines, for children presenting with acute asthma episodes in paediatric primary care, and hospital services including emergency departments.

Methods And Analysis: A cluster quasi-experimental implementation trial with a matched control group will be launched in a regional healthcare service. All the paediatric healthcare professionals providing care in two health districts (HDs) will receive interventions over two 12-month periods during which components of the implementation strategy to favour adoption of the AICP will be deployed cumulatively. A selected set of professionals from the same levels of care in the other HDs ( = 11) will serve as the comparison group. The target population of the AICP is children between 2 and 14 years old presenting with an acute asthma episode during the study period. A mixed methods evaluation guided by the RE-AIM framework will assess the effectiveness of the AICP after 12, 24, and 36 months in a set of pre-specified care and implementation outcomes at the professional level. The perceived feasibility of the AICP and its implementation from the perspective of physicians and the experience and satisfaction of patients concerning the clinical care received will be assessed through discussion groups.

Discussion: This study performed in real-world settings will contribute in extending knowledge in asthma care pathways beyond emergency settings into primary care and across the healthcare continuum. In addition, its findings aim to guide health systems in reducing variability in care, increasing guideline adherence, and ultimately improving paediatric asthma outcomes across the system.

Clinical Trial Registration: ClinicalTrials.gov, identifier [NCT06437444].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403179PMC
http://dx.doi.org/10.3389/fped.2025.1646499DOI Listing

Publication Analysis

Top Keywords

acute asthma
12
care
11
integrated care
8
care pathway
8
presenting acute
8
primary care
8
will
7
asthma
6
implementation
6
aicp
5

Similar Publications

Introduction: Lactate has emerged as a multifunctional signaling molecule regulating various physiological and pathological processes. Furthermore, lactylation, a newly identified posttranslational modification triggered by lactate accumulation, plays significant roles in human health and diseases. This study aims to investigate the roles of lactate/lactylation in respiratory diseases.

View Article and Find Full Text PDF

Asthma is one of the most prevalent chronic respiratory illnesses, significantly impacting patients through shortness of breath and even death. Acute exacerbations are usually controlled with a short-acting beta agonist, such as an albuterol inhaler, as well as long-acting agents to prevent the occurrence of exacerbations and status asthmaticus. Status asthmaticus is an emergent episode of asthma that is refractory to standard treatment.

View Article and Find Full Text PDF

Chronic airway diseases are a group of diseases, such as chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA), characterized pathologically by chronic airway inflammation, airway chronic mucus hypersecretion, and airway remodeling. Patients usually present with chronic coughing, expectoration, and dyspnea, and recurrent exacerbation is an important causative factor of increased mortality, along with the important triggers. Currently, existing treatment options cannot meet the clinical needs of chronic airway diseases.

View Article and Find Full Text PDF

Repurposing zafirlukast confers renal protection in ischemia-reperfusion injury via suppressing macrophage METosis.

Int Immunopharmacol

September 2025

Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China; Department of Pharmacology, School of Basic Medical Sciences, Wenzhou Medical University, 325035, Wenzhou, Zhejiang, China; State Key Laboratory for

Tacrolimus is widely used to prevent post-transplant acute kidney injury (AKI) but causes severe toxicities (e.g., nephrotoxicity, hyperglycemia).

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a chronic inflammatory skin condition often complicated by cardiovascular comorbidities, impacting treatment options and outcomes. In this paper, we present a 41-year-old patient with severe AD, asthma, and chronic heart failure, who responded well to dupilumab, showing significant improvements in skin severity scores and heart function. This case underscores the effectiveness of dupilumab in managing AD alongside complex comorbidities.

View Article and Find Full Text PDF